Company Filing History:
1 out of 832,812 Years Active: 2001
Title: Walburga Dieterich: Innovator in Immunological Methods
Introduction
Walburga Dieterich is a prominent inventor based in Berlin, Germany. She has made significant contributions to the field of immunology, particularly in the detection of antibodies related to tissue transglutaminase (tTG). Her innovative work has implications for diagnosing and managing autoimmune diseases, including coeliac disease.
Latest Patents
Walburga Dieterich holds a patent for an "Immunological method for detecting antibodies directed against tissue transglutaminase (tTG), use of tTG in diagnosis and therapy control, and an oral pharmaceutical agent containing tTG." This invention relates to a method for detecting antibodies from body fluids through an immune reaction with tTG. The method can be utilized in diagnosing and controlling therapy for diseases associated with immune reactions against tTG and its related compounds.
Career Highlights
Throughout her career, Walburga has focused on advancing the understanding of autoimmune diseases. Her work has been instrumental in developing diagnostic methods that can improve patient outcomes. She has dedicated her research to exploring the role of tTG in various chronic inflammatory conditions.
Collaborations
Walburga Dieterich has collaborated with notable colleagues in her field, including Detlef Schuppan and Tobias Ehnis. These collaborations have further enriched her research and contributed to the advancement of immunological methods.
Conclusion
Walburga Dieterich's innovative contributions to immunology highlight her role as a leading inventor in the field. Her patent on the detection of antibodies against tTG represents a significant advancement in the diagnosis and management of autoimmune diseases.